Strides Pharma Science

Strides Pharma Science Limited (STAR) is a global pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products across diverse international markets, including Africa, Australia, North America, Europe, Asia, and India. The company's operations are divided into two main segments: Pharmaceutical and Biopharmaceutical, reflecting its diverse product portfolio and capabilities.

The Pharmaceutical segment focuses on the production and distribution of generic pharmaceutical products. These generics are available in a wide array of dosage forms, catering to various medical needs. This includes common forms like tablets, capsules (both hard and soft gelatin), sachets, and liquids, as well as more specialized forms such as nasal sprays, gels, powders, ointments, and creams. This broad range ensures the company can address a significant portion of the market demand for generic medications.

Beyond generics, Strides Pharma Science also develops and markets branded generic products. These branded generics focus on chronic therapies, targeting specific therapeutic areas. This includes women's health, central nervous system disorders, cardiovascular conditions, diabetes, dermatological issues, and probiotics. Several brand names, including Renerve, Unibrol, Combiart, Duotab, and Vitafer, highlight their commitment to branded products within these therapeutic areas. This strategy allows them to differentiate themselves in the market and potentially command premium pricing for certain products.

A significant portion of Strides Pharma Science's business also involves supplying medications for institutional use. This includes crucial drugs used to combat infectious diseases such as anti-retrovirals (used in HIV/AIDS treatment), anti-malarials, anti-tuberculosis medications, Hepatitis treatments, and others. This institutional business segment points to a strategic focus on serving public health needs, particularly in regions facing significant challenges related to infectious diseases.

In summary, Strides Pharma Science Limited operates a multifaceted business model encompassing the production and sale of both generic and branded generic pharmaceutical products across a wide range of therapeutic areas and dosage forms, serving both individual consumers and institutional clients globally. Their strategic focus on chronic therapies and infectious disease treatments underscores their commitment to addressing major health challenges worldwide.